| Development and internal validation of a novel model to identify the candidates for extended pelvic lymph node dissection in prostate cancer G Gandaglia, N Fossati, E Zaffuto, M Bandini, P Dell’Oglio, CA Bravi, ... European urology 72 (4), 632-640, 2017 | 213 | 2017 |
| Robot-assisted radical prostatectomy with the novel Hugo robotic system: initial experience and optimal surgical set-up at a tertiary referral robotic center CA Bravi, M Paciotti, L Sarchi, A Mottaran, L Nocera, R Farinha, ... European Urology 82 (2), 233-237, 2022 | 73 | 2022 |
| Surgical safety of radical cystectomy and pelvic lymph node dissection following neoadjuvant pembrolizumab in patients with bladder cancer: prospective assessment of … A Briganti, G Gandaglia, S Scuderi, A Gallina, R Colombo, N Fossati, ... European urology 77 (5), 576-580, 2020 | 60 | 2020 |
| Efficacy of local treatment in prostate cancer patients with clinically pelvic lymph node-positive disease at initial diagnosis T Seisen, MW Vetterlein, P Karabon, T Jindal, A Sood, L Nocera, ... European urology 73 (3), 452-461, 2018 | 55 | 2018 |
| Incidence and survival rates of contemporary patients with invasive upper tract urothelial carcinoma CC Ruvolo, L Nocera, LF Stolzenbach, M Wenzel, V Cucchiara, Z Tian, ... European urology oncology 4 (5), 792-801, 2021 | 54 | 2021 |
| Bladder cancer: a comparison between non-urothelial variant histology and urothelial carcinoma across all stages and treatment modalities M Deuker, T Martin, F Stolzenbach, G Rosiello, CC Ruvolo, L Nocera, ... Clinical Genitourinary Cancer 19 (1), 60-68. e1, 2021 | 41 | 2021 |
| Overall survival and adverse events after treatment with darolutamide vs. apalutamide vs. enzalutamide for high-risk non-metastatic castration-resistant prostate cancer: a … M Wenzel, L Nocera, C Colla Ruvolo, C Würnschimmel, Z Tian, ... Prostate cancer and prostatic diseases 25 (2), 139-148, 2022 | 39 | 2022 |
| Clinical outcomes and adverse events after first-line treatment in metastatic renal cell carcinoma: a systematic review and network meta-analysis L Nocera, PI Karakiewicz, M Wenzel, Z Tian, SF Shariat, F Saad, ... The Journal of Urology 207 (1), 16-24, 2022 | 39 | 2022 |
| Neoadjuvant pembrolizumab and radical cystectomy in patients with muscle-invasive urothelial bladder cancer: 3-year median follow-up update of PURE-01 trial G Basile, M Bandini, EA Gibb, JS Ross, D Raggi, L Marandino, ... Clinical Cancer Research 28 (23), 5107-5114, 2022 | 37 | 2022 |
| Overall survival after systemic treatment in high-volume versus low-volume metastatic hormone-sensitive prostate cancer: systematic review and network meta-analysis M Wenzel, C Würnschimmel, L Nocera, CC Ruvolo, Z Tian, SF Shariat, ... European urology focus 8 (2), 399-408, 2022 | 37 | 2022 |
| Upper urinary tract tumors: variant histology versus urothelial carcinoma M Deuker, LF Stolzenbach, CC Ruvolo, L Nocera, Z Tian, FC Roos, ... Clinical Genitourinary Cancer 19 (2), 117-124, 2021 | 30 | 2021 |
| Functional outcomes of clinically high-risk prostate cancer patients treated with robot-assisted radical prostatectomy: a multi-institutional analysis F Abdollah, D Dalela, A Sood, J Sammon, R Cho, L Nocera, M Diaz, ... Prostate cancer and prostatic diseases 20 (4), 395-400, 2017 | 30 | 2017 |
| Outcomes of robot-assisted radical prostatectomy with the Hugo RAS surgical system: initial experience at a high-volume robotic center CA Bravi, M Paciotti, E Balestrazzi, A Piro, F Piramide, M Peraire, L Sarchi, ... European Urology Focus 9 (4), 642-644, 2023 | 29 | 2023 |
| Life expectancy in metastatic prostate cancer patients according to racial/ethnic groups C Würnschimmel, M Wenzel, C Colla Ruvolo, L Nocera, Z Tian, F Saad, ... International Journal of Urology 28 (8), 862-869, 2021 | 28 | 2021 |
| Robot-assisted sacropexy with the novel HUGO robot-assisted surgery system: initial experience and surgical setup at a tertiary referral robotic center A Mottaran, CA Bravi, L Sarchi, M Paciotti, L Nocera, A Piro, P Piazza, ... Journal of Endourology 37 (1), 35-41, 2023 | 23 | 2023 |
| Immunotherapy versus chemotherapy as first-line treatment for advanced urothelial cancer: a systematic review and meta-analysis A Martini, D Raggi, G Fallara, L Nocera, JG Schultz, F Belladelli, ... Cancer Treatment Reviews 104, 102360, 2022 | 23 | 2022 |
| Increasing rates of NCCN high and very high‐risk prostate cancer versus number of prostate biopsy cores M Wenzel, C Würnschimmel, CC Ruvolo, L Nocera, Z Tian, F Saad, ... The prostate 81 (12), 874-881, 2021 | 23 | 2021 |
| Robot-assisted simple prostatectomy with the novel HUGO™ RAS System: feasibility, setting, and perioperative outcomes. A Mottaran, M Paciotti, CA Bravi, L Sarchi, L Nocera, A Piro, R Farinha, ... Minerva Urology and Nephrology, 2022 | 21 | 2022 |
| Tumor size predicts muscle-invasive and non–organ-confined disease in upper tract urothelial carcinoma at radical nephroureterectomy CC Ruvolo, L Nocera, LF Stolzenbach, M Wenzel, G Califano, Z Tian, ... European Urology Focus 8 (2), 498-505, 2022 | 20 | 2022 |
| Incidence rates and contemporary trends in primary urethral cancer M Wenzel, L Nocera, C Colla Ruvolo, C Würnschimmel, Z Tian, ... Cancer Causes & Control 32, 627-634, 2021 | 20 | 2021 |
